Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System

JAMA Psychiatry. 2018 Apr 1;75(4):405-407. doi: 10.1001/jamapsychiatry.2017.4614.

Abstract

This analysis examines the association of death from overdose among individuals released from the Rhode Island correctional system after implementation of a comprehensive program of medications for addiction therapy.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Buprenorphine / adverse effects
  • Buprenorphine / therapeutic use*
  • Cause of Death / trends
  • Drug Overdose / mortality*
  • Female
  • Fentanyl / toxicity*
  • Health Plan Implementation*
  • Humans
  • Male
  • Methadone / adverse effects
  • Methadone / therapeutic use*
  • Middle Aged
  • Naltrexone / adverse effects
  • Naltrexone / therapeutic use*
  • Odds Ratio
  • Opioid-Related Disorders / mortality*
  • Opioid-Related Disorders / rehabilitation*
  • Patient Discharge / statistics & numerical data
  • Prisoners / statistics & numerical data*
  • Prisons / statistics & numerical data*
  • Retrospective Studies
  • Rhode Island
  • Transitional Care
  • Young Adult

Substances

  • Buprenorphine
  • Naltrexone
  • Methadone
  • Fentanyl